Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 May;7(5):515–518. doi: 10.1111/j.1365-2125.1979.tb00996.x

Phenytoin absorption in patients with ileojejunal bypass.

M C Kennedy, D N Wade
PMCID: PMC1429578  PMID: 475946

Abstract

1 The absorption and elimination of phenytoin was studied after a 200 mg oral dose was administered to seven patients with ileojejunal bypass and nine control patients. 2 Analysis of the area under the plasma concentration time curve showed the absorption of phenytoin was decreased in the subjects with ileojejunal bypass (P less than 0.005). 3 The half life of elimination of the drug was shorter in the bypass group (15.1 h) than in the controls (17.8 h, P less than 0.05). 4 Subjects with an ileojejunal bypass receiving phenytoin are likely to require increased oral dosages to achieve an optimal plasma concentration. There is probably malabsorption of other poorly soluble drugs and parenteral therapy may be necessary to ensure adequate bioavailability.

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gugler R., Manion C. V., Azarnoff D. L. Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther. 1976 Feb;19(2):135–142. doi: 10.1002/cpt1976192135. [DOI] [PubMed] [Google Scholar]
  2. Hall W. H., Doherty J. E. Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes. Am J Med. 1974 Apr;56(4):437–442. doi: 10.1016/0002-9343(74)90473-2. [DOI] [PubMed] [Google Scholar]
  3. Johansson E. D., Kral J. G. Oral contraceptives after intestinal bypass operations. JAMA. 1976 Dec 20;236(25):2847–2847. doi: 10.1001/jama.236.25.2847a. [DOI] [PubMed] [Google Scholar]
  4. Kutt H., Louis S. Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects. Drugs. 1972;4(3):227–255. doi: 10.2165/00003495-197204030-00003. [DOI] [PubMed] [Google Scholar]
  5. Marcus F. I., Quinn E. J., Horton H., Jacobs S., Pippin S., Stafford M., Zukoski C. The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man. Circulation. 1977 Mar;55(3):537–541. doi: 10.1161/01.cir.55.3.537. [DOI] [PubMed] [Google Scholar]
  6. Payne J. H., DeWind L. T. Surgical treatment of obesity. Am J Surg. 1969 Aug;118(2):141–147. doi: 10.1016/0002-9610(69)90113-5. [DOI] [PubMed] [Google Scholar]
  7. Peterson D. I., Zweig R. W. Absorption of anticonvulsants after jejunoileal bypass. Bull Los Angeles Neurol Soc. 1974 Apr;39(2):51–55. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES